These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 3039340)
21. Does [3H]2-methoxy-idazoxan (RX 821002) detect more alpha-2-adrenoceptor agonist high-affinity sites than [3H]rauwolscine? A comparison of nine tissues and cell lines. Erdbrügger W; Raulf M; Otto T; Michel MC J Pharmacol Exp Ther; 1995 Jun; 273(3):1287-94. PubMed ID: 7791100 [TBL] [Abstract][Full Text] [Related]
22. HepG2 and SK-N-MC: two human models to study alpha-2 adrenergic receptors of the alpha-2C subtype. Schaak S; Cayla C; Blaise R; Quinchon F; Paris H J Pharmacol Exp Ther; 1997 May; 281(2):983-91. PubMed ID: 9152409 [TBL] [Abstract][Full Text] [Related]
23. Ni-coupled receptors in cultured neural hybrid cells: cell specificity for dibutyryl cyclic AMP-induced down-regulation but not morphological differentiation. Noronha-Blob L; Lowe VC; Kinnier WJ; U'Prichard DC Mol Pharmacol; 1986 Dec; 30(6):526-36. PubMed ID: 3023808 [TBL] [Abstract][Full Text] [Related]
24. Human fat cell alpha-2 adrenoceptors. II. Comparative study of partial and full agonist binding parameters using [3H]clonidine and [3H]UK-14,304. Galitzky J; Lafontan M; Paris H; Berlan M J Pharmacol Exp Ther; 1989 May; 249(2):592-600. PubMed ID: 2566682 [TBL] [Abstract][Full Text] [Related]
25. Tight agonist binding may prevent the correct interpretation of agonist competition binding curves for alpha 2-adrenergic receptors. Convents A; De Backer JP; Convents D; Vauquelin G Mol Pharmacol; 1987 Jul; 32(1):65-72. PubMed ID: 2885739 [TBL] [Abstract][Full Text] [Related]
26. In vitro study of alpha 2-adrenoceptor turnover and metabolism using the adenocarcinoma cell line HT29. Paris H; Taouis M; Galitzky J Mol Pharmacol; 1987 Nov; 32(5):646-54. PubMed ID: 2891026 [TBL] [Abstract][Full Text] [Related]
27. The effects of tetramethylpyrazine on the human platelet alpha 2 adrenergic receptor adenylate cyclase system. Hui KK; Yu JL; Tse E; Borst S Res Commun Chem Pathol Pharmacol; 1987 Oct; 58(1):3-14. PubMed ID: 2829329 [TBL] [Abstract][Full Text] [Related]
28. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. I. High- and low-affinity states of agonist binding to membrane-bound beta adrenergic receptors. Contreras ML; Wolfe BB; Molinoff PB J Pharmacol Exp Ther; 1986 Apr; 237(1):154-64. PubMed ID: 2870174 [TBL] [Abstract][Full Text] [Related]
29. Evidence for the role of epinephrine binding frequency in activation of adenylate cyclase. Stickle D; Barber R Mol Pharmacol; 1989 Sep; 36(3):437-45. PubMed ID: 2550777 [TBL] [Abstract][Full Text] [Related]
30. Alpha 2A-adrenoceptors mediate activation of non-selective cation channels via Gi-proteins in human erythroleukaemia (HEL) cells. No evidence for a functional role of imidazoline receptors in modulating calcium. Musgrave IF; Seifert R Biochem Pharmacol; 1995 Jan; 49(2):187-96. PubMed ID: 7530955 [TBL] [Abstract][Full Text] [Related]
31. Phorbol ester and staurosporine modulation of antagonist and agonist binding to alpha-2 adrenergic receptors: differential influence on Na+ versus guanylylnucleotide regulation. Jagadeesh G; Deth RC J Pharmacol Exp Ther; 1992 Aug; 262(2):775-83. PubMed ID: 1323662 [TBL] [Abstract][Full Text] [Related]
32. Altered adrenergic response and specificity of the receptors in rat ascites hepatoma AH130. Sanae F; Miyamoto K; Koshiura R Cancer Res; 1989 Nov; 49(22):6242-6. PubMed ID: 2553251 [TBL] [Abstract][Full Text] [Related]
33. Two distinct populations of [3H]prazosin and [3H]yohimbine binding sites in the plasma membranes of rat mesenteric artery. Agrawal DK; Daniel EE J Pharmacol Exp Ther; 1985 Apr; 233(1):195-203. PubMed ID: 2984413 [TBL] [Abstract][Full Text] [Related]
35. Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding. Williams LT; Snyderman R; Lefkowitz RJ J Clin Invest; 1976 Jan; 57(1):149-55. PubMed ID: 1245597 [TBL] [Abstract][Full Text] [Related]
36. Relationship between alpha 2-adrenergic receptor binding sites and the functional receptors inhibiting norepinephrine release in rat cerebral cortex. Nasseri A; Minneman KP Mol Pharmacol; 1987 Nov; 32(5):655-62. PubMed ID: 2891027 [TBL] [Abstract][Full Text] [Related]
37. High affinity binding of 3H rauwolscine and 3H RX781094 to alpha 2 adrenergic receptors and non-stereoselective sites in human and rabbit brain cortex membranes. Convents A; Convents D; De Backer JP; De Keyser J; Vauquelin G Biochem Pharmacol; 1989 Feb; 38(3):455-63. PubMed ID: 2563652 [TBL] [Abstract][Full Text] [Related]
38. Effect of islet-activating pertussis toxin on the binding characteristics of Ca2+-mobilizing hormones and on agonist activation of phosphorylase in hepatocytes. Lynch CJ; Prpic V; Blackmore PF; Exton JH Mol Pharmacol; 1986 Feb; 29(2):196-203. PubMed ID: 3005828 [TBL] [Abstract][Full Text] [Related]
39. Characterization of alpha 2-adrenergic receptors of calf retina membranes by [3H]-rauwolscine and [3H]-RX 781094 binding. Convents A; De Backer JP; Vauquelin G Biochem Pharmacol; 1987 Aug; 36(15):2497-503. PubMed ID: 3038126 [TBL] [Abstract][Full Text] [Related]
40. Differences between agonist and antagonist binding to alpha 1-adrenergic receptors of intact and broken-cell preparations. Sladeczek F; Bockaert J; Mauger JP Mol Pharmacol; 1983 Nov; 24(3):392-7. PubMed ID: 6138703 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]